Development and Validation of a Quantitative Coronary CT Angiography Model for Diagnosis of Vessel-Specific Coronary Ischemia
Nick S Nurmohamed,Ibrahim Danad,Ruurt A Jukema,Ruben W de Winter,Robin J de Groot,Roel S Driessen,Michiel J Bom,Pepijn van Diemen,Gianluca Pontone,Daniele Andreini,Hyuk-Jae Chang,Richard J Katz,Erik S G Stroes,Hao Wang,Chung Chan,Tami Crabtree,Melissa Aquino,James K Min,James P Earls,Jeroen J Bax,Andrew D Choi,Paul Knaapen,Alexander R van Rosendael,CREDENCE and PACIFIC-1 Investigators,Ran Heo,Hyung-Bok Park,Hugo Marques,Wijnand J Stuijfzand,Jung Hyun Choi,Joon-Hyung Doh,Ae-Young Her,Bon-Kwon Koo,Chang-Wook Nam,Sang-Hoon Shin,Jason Cole,Alessia Gimelli,Muhammad Akram Khan,Bin Lu,Yang Gao,Faisal Nabi,Mouaz H Al-Mallah,Ryo Nakazato,U Joseph Schoepf,Randall C Thompson,James J Jang,Michael Ridner,Chris Rowan,Erick Avelar,Philippe Généreux,Guus A de Waard,Ralf W Sprengers,Pieter G Raijmakers
DOI: https://doi.org/10.1016/j.jcmg.2024.01.007
Abstract:Background: Noninvasive stress testing is commonly used for detection of coronary ischemia but possesses variable accuracy and may result in excessive health care costs. Objectives: This study aimed to derive and validate an artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT) model for the diagnosis of coronary ischemia that integrates atherosclerosis and vascular morphology measures (AI-QCTISCHEMIA) and to evaluate its prognostic utility for major adverse cardiovascular events (MACE). Methods: A post hoc analysis of the CREDENCE (Computed Tomographic Evaluation of Atherosclerotic Determinants of Myocardial Ischemia) and PACIFIC-1 (Comparison of Coronary Computed Tomography Angiography, Single Photon Emission Computed Tomography [SPECT], Positron Emission Tomography [PET], and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve) studies was performed. In both studies, symptomatic patients with suspected stable coronary artery disease had prospectively undergone coronary computed tomography angiography (CTA), myocardial perfusion imaging (MPI), SPECT, or PET, fractional flow reserve by CT (FFRCT), and invasive coronary angiography in conjunction with invasive FFR measurements. The AI-QCTISCHEMIA model was developed in the derivation cohort of the CREDENCE study, and its diagnostic performance for coronary ischemia (FFR ≤0.80) was evaluated in the CREDENCE validation cohort and PACIFIC-1. Its prognostic value was investigated in PACIFIC-1. Results: In CREDENCE validation (n = 305, age 64.4 ± 9.8 years, 210 [69%] male), the diagnostic performance by area under the receiver-operating characteristics curve (AUC) on per-patient level was 0.80 (95% CI: 0.75-0.85) for AI-QCTISCHEMIA, 0.69 (95% CI: 0.63-0.74; P < 0.001) for FFRCT, and 0.65 (95% CI: 0.59-0.71; P < 0.001) for MPI. In PACIFIC-1 (n = 208, age 58.1 ± 8.7 years, 132 [63%] male), the AUCs were 0.85 (95% CI: 0.79-0.91) for AI-QCTISCHEMIA, 0.78 (95% CI: 0.72-0.84; P = 0.037) for FFRCT, 0.89 (95% CI: 0.84-0.93; P = 0.262) for PET, and 0.72 (95% CI: 0.67-0.78; P < 0.001) for SPECT. Adjusted for clinical risk factors and coronary CTA-determined obstructive stenosis, a positive AI-QCTISCHEMIA test was associated with aHR: 7.6 (95% CI: 1.2-47.0; P = 0.030) for MACE. Conclusions: This newly developed coronary CTA-based ischemia model using coronary atherosclerosis and vascular morphology characteristics accurately diagnoses coronary ischemia by invasive FFR and provides robust prognostic utility for MACE beyond presence of stenosis.